急性烧伤复苏期间血管加压药的使用
该回顾性研究分析了52例烧伤面积≥20%TBSA的成人患者,31%在复苏期间使用血管加压药。血管加压药使用与年龄及高剂量维生素C独立相关,与白蛋白使用呈负相关;需大型随机研究验证。
要点
- 31%的≥20%TBSA烧伤成人在急性复苏期使用血管加压药
- 高龄是血管加压药使用的独立危险因素
- 高剂量维生素C与血管加压药使用增加相关,白蛋白与使用减少相关
核心结论
- 高龄似乎是烧伤复苏期间使用血管加压药的最重要决定因素。
- 高剂量维生素C可能增加血管加压药需求,白蛋白可能减少需求,但需大型随机研究正式评估。
研究设计与样本
- 回顾性综述,纳入一家ABA认证区域烧伤中心的52例烧伤面积≥20%TBSA的成人患者。
- PRESSOR组为伤后48小时内接受血管加压药输注至少30分钟的患者(N=16),NoPRESSOR组为未接受血管加压药的患者(N=36)。
主要发现
- 31%的患者在复苏期间接受了血管加压药。
- 血管加压药输注始于伤后20.9±10.9小时,持续16.8±10.8小时。
- PRESSOR组患者的总烧伤面积(p=0.001)、全层烧伤面积(p<0.001)及机械通气需求(p=0.005)显著高于NoPRESSOR组。
- 两组第一个24小时预测液体量百分比无显著差异(143±58% vs 125±46%)。
- PRESSOR组较NoPRESSOR组更少使用5%白蛋白(38% vs 47%),更多使用高剂量维生素C(69% vs 17%)。
关键数值与推荐
- 多因素回归分析显示年龄(OR 1.189,95%CI:1.047,1.351)和高剂量维生素C(OR 24.701,95%CI:1.558,391.551)与血管加压药使用增加独立相关。
- 逆概率加权倾向分析显示高剂量维生素C与血管加压药使用增加显著相关(OR 6.902,95%CI:2.503,19.026),白蛋白使用与血管加压药使用减少显著相关(OR 0.310,95%CI:0.130,0.739)。
临床怎么用
- 对于高龄、大面积或全层烧伤及需要机械通气的患者,应警惕复苏期间可能需要血管加压药。
- 高剂量维生素C与血管加压药使用增加相关,白蛋白与使用减少相关,临床决策时需考虑这些关联但不应视为因果。
局限性
- 回顾性研究设计,样本量较小(52例),仅来自单一中心。
- 高剂量维生素C和白蛋白与血管加压药使用的关联需大型随机研究正式评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vasopressors may be required during acute burn resuscitation to support mean arterial blood pressure, but their use is not well-described in the burn literature. The purpose of this study was to examine vasopressor use during acute fluid resuscitation. METHODS: Retrospective review of adults with burns ≥ 20% TBSA admitted to an ABA-verified regional burn center. Patients administered an infusion of a vasopressor for at least 30 min during the 1 st 48 h post-burn formed the PRESSOR group while patients who did not receive vasopressors formed the NoPRESSOR group. RESULTS: We studied 52 burned adults, 85% of which had flame burns. Vasopressors were administered during resuscitation to 31% of patients. Vasopressor infusions began at 20.9 ± 10.9 h post burn and were continued for 16.8 ± 10.8 h. PRESSOR patients (N = 16) had significantly greater total (p = 0.001) and full thickness burn size (p < 0.001), and need for mechanical ventilation (p = 0.005) than NoPRESSOR patients (N = 36). PRESSOR and NoPRESSOR patients did not differ significantly in per cent predicted fluid volume received in the first 24 h (143 ± 58 Vs. 125 ± 46 respectively). PRESSOR patients compared to NoPRESSOR patients tended to have been administered 5% albumin (Alb) less often (38% Vs 47%) and high dose vitamin C (HDVC) more often during resuscitation (69% vs 17%). Multivariate regression analysis found that patient age (OR 1.189, 95% CI: 1.047, 1.351) and HDVC (OR 24.701, 95% CI: 1.558, 391.551) were independently associated with greater use of vasopressors. An inverse probability weighted propensity analysis also identified a significant association between HDVC and increased use of vasopressors (OR 6.902, 95 % CI: 2.503, 19.026), and significantly decreased vasopressor administration following Alb administration (OR 0.310, 95% CI: 0.130, 0.739). CONCLUSION: Advanced age appears to be the most important determinant of vasopressor use during resuscitation. While vasopressor requirements appear to have been increased by HDVC and decreased by Alb, this needs to be formally evaluated in a large randomized study.
引用
- Adibfar A, Camacho F, Rogers AD, et al. The use of vasopressors during acute burn resuscitation. Burns. 2020. PMID: 33293152. doi:10.1016/j.burns.2020.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。